Disclaimer: Educational article for athletes and coaches. Not medical advice. Do not start, stop, or adjust medication based on this text. Speak with a clinician about personal treatment and monitoring.
“Am I losing muscle on GLP-1?” is the question behind half of modern physique coaching emails. The honest answer starts with definitions, then trial numbers, then function, then habits that are reasonable while definitive trials finish.
Lean mass is not the same as muscle
DXA lean mass includes skeletal muscle but also organs, body water, and other non-fat soft tissue. MRI muscle volume and strength tests answer different questions. A Circulation review of muscle changes with GLP-1 receptor agonists stresses this measurement problem and discusses whether observed changes look adaptive (expected with weight loss and sometimes accompanied by better muscle quality) or potentially maladaptive in vulnerable people. See Neeland et al., Circulation.
For coaching, that means: treat a falling lean-mass number as a signal to investigate training quality, protein intake, and strength, not as a courtroom verdict that “all the muscle is gone.”
What STEP-1 and SURMOUNT-1 composition data showed
In body-composition analyses summarized in the muscle-and-GLP-1 literature, a STEP-1 DXA analysis attributed about 45% of total weight lost to lean mass, while a SURMOUNT-1 analysis attributed about 26% of weight lost to lean mass. Absolute lean-mass reductions were several kilograms on average in those substudies, alongside larger fat-mass losses. See Neeland et al., Circulation for the framing of these trial findings and the broader adaptive-versus-concerning discussion.
Two coaching takeaways follow. First, some lean tissue loss during large weight reduction is expected across many methods, including diet alone and bariatric surgery. Second, the fraction varies by drug, population, measurement, and lifestyle support. Heterogeneity is the rule, not the exception.
SEMALEAN: mass fell, grip improved
SEMALEAN study (doi:10.1111/dom.70141) adds a useful longitudinal picture in people with obesity on semaglutide 2.4 mg. Across roughly 12 months, mean weight reduction reached about 13%, fat mass fell more steeply (on the order of 18% relative reduction by month 12 in the reported results), lean mass dropped early by about 3 kg then leveled, and handgrip strength rose by about 4.5 kg on average. Sarcopenic obesity prevalence fell from about 49% to 33% in that cohort.
That combination undercuts simplistic panic narratives. People can lose some lean mass and still gain strength metrics, especially if baseline function was limited by excess fat and low fitness. It also undercuts complacency: early lean-mass decline still happened, so monitoring remains wise.
ADA guidance context
Obesity care standards highlight pharmacotherapy within a broader plan that includes nutrition and attention to lean mass preservation strategies such as protein intake and muscle-strengthening activity. See the ADA Standards of Care 2026 (obesity section) and doi:10.2337/dc26-s008. That is clinical guidance for care teams, not a gym prescription template, but it aligns with how thoughtful coaches already work during weight loss.
Strategies being studied (not proven GLP-1 specific cures)
Resistance training and higher protein intakes are long-standing sports-nutrition tools during energy deficit. Their specific effect sizes during modern GLP-1 or dual-agonist therapy are still being quantified.
LEAN-PREP protocol (BMJ Open) (registered as ClinicalTrials.gov NCT06885736) is a randomized protocol testing home-based resistance exercise three times weekly and/or protein targeting about 1.6 g/kg/day during semaglutide or tirzepatide initiation, with MRI quadriceps cross-sectional area as the primary endpoint. Until results are published, coaches should describe these approaches as reasonable, consensus-aligned strategies under study, not as guaranteed muscle locks.
A practical muscle-retention checklist for coaches
Training
- Protect weekly hard sets for major muscle groups. Two to four sessions usually beat sporadic “when I feel like it” lifting during appetite suppression.
- Favor compound patterns the client can recover from. Cut junk volume before you cut meaningful progressive work.
- Log performance. If squat, hinge, push, and pull numbers slide for several weeks while weight falls fast, raise the flag with the client and their clinician or dietitian.
Protein and energy
- Help clients find protein sources they still enjoy when full early: dairy or lactose-free options, eggs, fish, lean meats, soy, or medical nutrition products if a clinician recommends them.
- Avoid extreme self-imposed deficits on top of medication-driven intake reduction unless a clinician and dietitian designed that plan.
- Spread protein across meals when possible. Digestion comfort matters more than perfect textbook timing.
Monitoring
- Combine scale weight with waist, training logs, and at least one function test (grip, sit-to-stand, timed walk, or loaded carry distance).
- If available and clinically appropriate, DXA or other composition tests belong in the medical or specialist lane, interpreted with the caveats above. See Neeland et al., Circulation.
Who needs extra caution
Older adults, people with low baseline muscle, chronic illness, or repeated crash dieting may tolerate lean-mass loss poorly. Circulation authors discuss age and prefrailty as factors that influence whether muscle change stays adaptive. See Neeland et al., Circulation. Coaches should slow aesthetic timelines, prioritize strength, and escalate medical follow-up sooner for these clients.
Language that helps clients
Replace “GLP-1 melts muscle” with “large weight loss usually includes some lean tissue, so we train and eat to protect function.” Replace “just eat more protein and you are safe” with “protein plus lifting are sensible and under study; we will track strength while your clinician manages therapy.” That tone matches the evidence maturity of 2026.
Bottom line
GLP-1 associated weight loss can include meaningful lean-mass reduction in trial DXA data, yet function and muscle quality findings are more nuanced, and SEMALEAN shows strength can improve even as lean mass shifts. See Neeland et al., Circulation and SEMALEAN study (doi:10.1111/dom.70141). Coaches should double down on resistance training, adequate protein, and functional monitoring, stay inside non-prescribing boundaries, and treat ongoing trials like LEAN-PREP as the next chapter rather than marketing copy. See LEAN-PREP protocol (BMJ Open) and ADA Standards of Care 2026 (obesity section).
Putting numbers in coaching context
Clients often hear “up to half the weight lost can be lean mass” and conclude the worst. The STEP-1 DXA fraction near 45% and the SURMOUNT-1 fraction near 26% are real trial signals summarized in the muscle-and-GLP-1 literature, but they are group averages from specific substudies, not personal forecasts. See Neeland et al., Circulation. Absolute lean-mass change also depends on how large total weight loss is. Someone losing modest weight will not automatically lose the same kilograms of lean tissue as a participant who lost more than 15 kg in a registration trial.
Coaches can reframe the conversation around three controllable levers: training stimulus, protein adequacy, and pace of loss that the clinical team considers appropriate. You do not control the prescription. You do control whether the gym week still includes progressive resistance work when appetite is quiet.
How to talk about body-composition tests
If a client brings a DXA or bioimpedance printout, teach the limits before teaching the drama. Different devices disagree. Hydration shifts lean readings. Compare trends measured the same way rather than shopping for the friendliest number. Circulation authors emphasize that muscle quantity, composition, and function are related but not identical constructs. See Neeland et al., Circulation.
When possible, pair any composition test with a strength log and a simple function screen. SEMALEAN’s pattern of early lean-mass decline with later stabilization and rising handgrip is a concrete example of why a single lean-mass snapshot can mislead. See SEMALEAN (doi:10.1111/dom.70141).
Studio systems that support retention
Studios that already sell strength packages are well positioned. Build onboarding questions that ask whether a clinician is involved, whether appetite has changed around training times, and whether the client has a dietitian. Offer a short “function baseline” day: grip if available, sit-to-stand, a loaded carry distance, and two main lifts at a submaximal RPE. Re-test every 6 to 8 weeks.
Keep education materials aligned with ADA comprehensive-care framing and with ongoing trials such as LEAN-PREP, so staff do not invent GLP-1 specific miracle protocols. See ADA Standards of Care 2026 (obesity section), doi:10.2337/dc26-s008, and LEAN-PREP protocol / NCT06885736.
